SCHEMBL8676708

SCHEMBL8676708

[CH2]CCC=C(c1ccc(F)cc1)c1cccnc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TBXAS1 P24557 15/20 0.65
TBXA2R P21731 1/20 0.51
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2D6 P10635 1/20 0.51
CYP2C9 P11712 1/20 0.51
ALOX15 P16050 1/20 0.51
NFKB1 P19838 1/20 0.51
CYP2C19 P33261 1/20 0.51
HIF1A Q16665 1/20 0.51
ADRA2A P08913 1/20 0.51
DRD2 P14416 1/20 0.51
ADRA2B P18089 1/20 0.51
ADRA2C P18825 1/20 0.51
HTR2C P28335 1/20 0.51
SLC6A4 P31645 1/20 0.51
ADRA1A P35348 1/20 0.51
HRH1 P35367 1/20 0.51
OPRM1 P35372 1/20 0.51
DRD3 P35462 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8676706 1.00 TBXAS1 (0.65) TBXAS1TBXA2RCYP1A2CYP3A4CYP2D6
SCHEMBL9030628 0.84 TBXAS1 (0.71) TBXAS1TBXA2R
SCHEMBL9030728 0.84 TBXAS1 (0.71) TBXAS1TBXA2R
SCHEMBL9030641 0.84 TBXAS1 (0.71) TBXAS1TBXA2R
SCHEMBL9032871 0.83 TBXAS1 (0.70) TBXAS1TBXA2R
SCHEMBL9032879 0.83 TBXAS1 (0.70) TBXAS1TBXA2R
SCHEMBL9032883 0.83 TBXAS1 (0.70) TBXAS1TBXA2R
SCHEMBL8675717 0.83 TBXAS1 (0.41) TBXAS1
Hydrochloric Acid SCHEMBL9031084 0.82 TBXAS1 (0.68) TBXAS1TBXA2R
Hydrochloric Acid SCHEMBL9031078 0.82 TBXAS1 (0.68) TBXAS1TBXA2R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5840896-A PREPARING 2-AMINOCARBONYL-N-(4-AMINO-2,6-DICHLOROPHENYL)-4-(5,5-BIS(4-FLUOROPHENYL) -PENTYL)-1-PIPERAZINEACETAMIDE; CYCLIZATION; HYDROGENATION CATALYSIS; REDUCTIVE N-ALKYLATION JANSSEN PHARMACEUTICA, N.V. (BE) 1998-11-24 US disclosed
EP-0577171-A2 Use of piperazine acetamide derivatives against reperfusion damage JANSSEN PHARMACEUTICA N.V. (BE) 1994-01-05 EP disclosed
EP-0455789-A1 METHOD OF PREVENTING OR LIMITING REPERFUSION DAMAGE. JANSSEN PHARMACEUTICA NV (BE) 1991-11-13 EP disclosed
WO-1991007967-A2 METHOD OF PREVENTING OR LIMITING REPERFUSION DAMAGE JANSSEN PHARMACEUTICA N.V. (BE) 1991-06-13 WO disclosed